The Clorox Company (CLX) Analyse boursière

Présentation de l'entreprise

The Clorox Company manufactures and markets consumer and professional products worldwide, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. This enterprise functions within the Consumer Defensive sector, specifically targeting the Household & Personal Products industry, which typically exhibits lower sensitivity to economic cycles compared to cyclical sectors. The company's scale is substantial, evidenced by a market capitalization of $12.89B, annual revenue of $6.76B, and an employee count of 7600. These valuation and revenue figures indicate that the entity holds a significant position within its niche, commanding a large market cap that reflects its established brand presence and operational breadth across global markets.

Santé financière

The company generated revenue of $6.76B over the trailing twelve months, resulting in a net income of $755.00M and an EBITDA of $1.23B, while the gap between revenue and net income reveals a cost structure that includes approximately $6.005B in combined operating expenses, taxes, and interest costs. Free cash flow stands at $1.00B, which signifies a robust capacity to fund capital expenditures, service debt obligations, or return capital to shareholders without relying on external financing. The gross margin of 44.2% indicates strong pricing power and efficient supply chain management, whereas the operating margin of 14.0% and profit margin of 11.2% demonstrate the company's ability to control overhead and translate sales into bottom-line profit. However, the balance sheet presents a leveraged profile, as total debt of $3.22B significantly exceeds cash reserves of $227.00M, resulting in a debt-to-equity ratio of 9191.43 that suggests high leverage relative to equity. Short-term liquidity appears constrained by a current ratio of 0.74, indicating that current assets may be insufficient to cover current liabilities without relying on new financing or asset sales. Return on Equity reaches 987.2% and Return on Assets sits at 11.3%, metrics that suggest high financial leverage is amplifying returns but also highlight the sensitivity of equity value to changes in debt levels.

Évaluation de la valorisation

The trailing P/E ratio is 17.29, while the forward P/E is 15.71, implying that the market expects earnings growth that would justify a lower multiple in the future relative to historical performance. The price-to-book ratio is listed as -102.20, a figure that technically indicates a negative valuation metric often associated with accounting anomalies or significant goodwill impairments rather than a standard market premium over tangible book value. Alternative valuation metrics such as the price-to-sales ratio of 1.91 and the EV/EBITDA of 12.97 suggest the stock is priced at a premium relative to its sales and earnings before interest, taxes, depreciation, and amortization, reflecting confidence in its defensive characteristics. The 52-week high was $143.96 and the low was $96.66, meaning the current trading price sits at a specific point within this range that requires calculation against the latest market data to determine exact percentage positioning. With a beta of 0.65, the stock exhibits lower price volatility relative to the broader market, making it attractive for portfolios seeking stability during periods of equity market turbulence.

Growth & Income

Revenue growth year-over-year stands at -0.8%, while earnings growth year-over-year is -16.2%, indicating that earnings are contracting at a significantly faster rate than revenue, which points to cost pressures or margin compression impacting profitability disproportionately to top-line sales. As a dividend payer, the company offers a dividend yield of 4.7% with a payout ratio of 80.5%, suggesting that a substantial portion of earnings is distributed to shareholders, which must be monitored given the recent earnings contraction to assess sustainability. The high payout ratio combined with negative earnings growth implies a need for careful management of cash flow to maintain dividend levels without eroding financial flexibility. Overall, the growth and income profile presents a defensive income-oriented asset that is currently facing headwinds in earnings expansion while maintaining a high yield relative to its market capitalization.